Latest filing published 15 Apr 2025 for TherapeuticsMD, Inc., €431. Read the official filing
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Marlan D. Walker (board member) discloses dealings in TherapeuticsMD, Inc. to SEC (Form 4). Between 10 May 2021 and 14 April 2025, the trades on record add up to 9 filings.
Purchases make up the whole of the open-market record (2 purchases, €1,339). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The rest of the record consists of 7 option exercises. So far in 2025, the count stands at 2 purchases and no sales.
The record was last updated on 15 April 2025 with an open-market purchase (€431) in TherapeuticsMD, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 of 9 declarations